Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Genome Editing Made Possible on Cells Lining Blood Vessel Walls
Scientific Advances

Genome Editing Made Possible on Cells Lining Blood Vessel Walls

By Ann & Robert H. Lurie Children's Hospital of ChicagoJan 14, 2022
Share
Facebook Twitter Email
YouYang Zhao, PhD, professor of Pediatrics in the Division of Critical Care and member of the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, was senior author of the study published in Cell Reports.

Northwestern Medicine scientists developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells, which line blood vessel walls.

Published in Cell Reports, this is the first time that vascular endothelial cells could be reached for genome editing, since the usual way to deliver CRISPR/Cas9 – through a virus – does not work for this cell type, according to YouYang Zhao, PhD, professor of Pediatrics in the Division of Critical Care and senior author of the study.

“The nanoparticle we developed is a powerful new delivery system for genome editing in vascular endothelial cells, and could be used to treat many diseases, including acute respiratory distress syndrome from severe COVID-19,” said Zhao, who is a member of the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago. “With this nanoparticle we can introduce genes to inhibit vascular injury or promote vascular repair, correct gene mutations and turn genes on or off to restore normal function. It also allows us to edit multiple genes at the same time. This is an important advance for treating any disease caused by endothelial dysfunction.”

Endothelial dysfunction is at the root of many diseases, such as coronary artery disease, stroke, bronchopulmonary dysplasia and pulmonary artery hypertension. Zhao explained that genome editing in endothelial cells could even treat cancers by cutting off the blood supply to the tumor or blocking cancer metastasis.

At this stage, Dr. Zhao and colleagues achieved excellent results in a mouse model. The nanoparticle carrying CRISPR/Cas9 plasmid DNA was introduced via a one-time IV injection and required a few days to be effective. Preclinical testing will be necessary before clinical trials can begin.

“Our nanoparticle delivery system for genome editing and transgene expression also is a huge advance for cardiovascular research,” Zhao added.

Zhao is also a professor of Medicine in the Division of Pulmonary and Critical Care and of Pharmacology.

Research at Ann & Robert H. Lurie Children’s Hospital of Chicago is conducted through the Stanley Manne Children’s Research Institute. The Manne Research Institute is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report. It is the pediatric training ground for Northwestern University Feinberg School of Medicine. Last year, the hospital served more than 220,000 children from 48 states and 49 countries.

 

Genetics Pediatrics Research
Share. Facebook Twitter Email

Related Posts

Inflammatory Signaling Linked to Leukemia Progression

Aug 15, 2022

Emerging Therapy for Relapsed Lymphoma

Aug 12, 2022

Scientists Identify Key Mechanism Controlling Skin Regeneration

Aug 11, 2022

Comments are closed.

Latest News

Inflammatory Signaling Linked to Leukemia Progression

Aug 15, 2022

Emerging Therapy for Relapsed Lymphoma

Aug 12, 2022

Scientists Identify Key Mechanism Controlling Skin Regeneration

Aug 11, 2022

Scientists Discover Novel Cellular Mechanisms Behind Transcription Elongation

Aug 10, 2022

First-Year Medical Students Celebrate Founders’ Day 2022

Aug 9, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
egn-flickr
Founders' Day 2022_EGN-retouched
220805_SERIO_MANDELL_FEINBERG_White_Coat_1676
220805_SERIO_MANDELL_FEINBERG_White_Coat_1206
220805_SERIO_MANDELL_FEINBERG_White_Coat_1144 (1)
220805_SERIO_MANDELL_FEINBERG_White_Coat_1133
220805_SERIO_MANDELL_FEINBERG_White_Coat_1057
220805_SERIO_MANDELL_FEINBERG_White_Coat_1424
220805_SERIO_MANDELL_FEINBERG_White_Coat_1472
220805_SERIO_MANDELL_FEINBERG_White_Coat_1573
220805_SERIO_MANDELL_FEINBERG_White_Coat_1671
220805_SERIO_MANDELL_FEINBERG_White_Coat_1793

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.